Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial.
暂无分享，去创建一个
P. Ascierto | S. Aamdal | L. Bastholt | P. Rutkowski | P. Patel | S. Suciu | N. Davidson | P. Corrie | M. Santinami | L. Borgognoni | A. Spatz | W. Kruit | M. Bernengo | J. Marsden | A. Eggermont | M. Praet | L. Polders